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Abstract
Memory CD8
+ T cells represent an important effector arm of the immune response in maintaining long-lived protective
immunity against viruses and some intracellular bacteria such as Listeria monocytogenes (L.m). Memory CD8
+ T cells are
endowed with enhanced antimicrobial effector functions that perfectly tail them to rapidly eradicate invading pathogens. It
is largely accepted that these functions are sufficient to explain how memory CD8
+ T cells can mediate rapid protection.
However, it is important to point out that such improved functional features would be useless if memory cells were unable
to rapidly find the pathogen loaded/infected cells within the infected organ. Growing evidences suggest that the anatomy
of secondary lymphoid organs (SLOs) fosters the cellular interactions required to initiate naive adaptive immune responses.
However, very little is known on how the SLOs structures regulate memory immune responses. Using Listeria
monocytogenes (L.m) as a murine infection model and imaging techniques, we have investigated if and how the
architecture of the spleen plays a role in the reactivation of memory CD8
+ T cells and the subsequent control of L.m growth.
We observed that in the mouse, memory CD8
+ T cells start to control L.m burden 6 hours after the challenge infection. At
this very early time point, L.m-specific and non-specific memory CD8
+ T cells localize in the splenic red pulp and form
clusters around L.m infected cells while naı ¨ve CD8
+ T cells remain in the white pulp. Within these clusters that only last few
hours, memory CD8
+ T produce inflammatory cytokines such as IFN-c and CCL3 nearby infected myeloid cells known to be
crucial for L.m killing. Altogether, we describe how memory CD8
+ T cells trafficking properties and the splenic micro-
anatomy conjugate to create a spatio-temporal window during which memory CD8
+ T cells provide a local response by
secreting effector molecules around infected cells.
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Introduction
The protective immune response against pathogenic microor-
ganisms involves two components: a rapid, antigen non-specific
innate response and a delayed, acquired response specific for the
antigens (Ags) displayed by invading microbes. The efficacy of
these responses relies on multiple effector functions such as the
secretion of antimicrobial molecules and the direct killing of
infected cells by effector lymphocytes [1]. However, these
mechanisms are only the final steps of a long cascade of events
that began several days before. Naı ¨ve T lymphocytes endlessly
patrol the T cell zones of all secondary lymphoid organs (SLOs)
[2,3]. Upon an infection, homing to the relevant infected SLO
represents the first challenge for rare Ag-specific T cells. In order
to be primed, lymphocytes further need to find the Ag-loaded cells
amongst millions of other SLO wandering cells. Growing
evidences suggest that the structure of SLOs plays an active role
in this search [4]. For instance, Ag-loaded DCs derived from
inflamed tissues migrate via lymphatics to the draining LN where
they settle close to High Endothelial Venules (HEVs), forming a
‘‘gauntlet’’ of Ag through which blood incoming cells will have to
pass upon their exit from the HEVs [5]. Meanwhile, draining LNs
massively recruit blood circulating naı ¨ve T cells via their inflamed
HEVs, increasing the efficacy of this screening process [6,7]. While
the ability of a lymphocyte to visit all LNs is critical for a thorough
monitoring of potential infections, it can also be viewed as
distracting the cell from where it is mostly needed upon infection
namely the SLO draining the infected site. This notion is crucial
since lymphocytes wander approximately 12 hours in a given SLO
before they can return to the blood circulation and get another
opportunity to home to the SLO draining this inflamed tissue [3].
In this context, the rapidity and efficacy of memory cells to
control secondary infections are puzzling. Memory CD8
+ T cells
are endowed with enhanced antimicrobial effector functions and
properties including increased lifespan and higher division rate
that perfectly tail them to rapidly eradicate invading pathogens
[8]. However, such functional features would be useless if memory
cells were unable to rapidly find the pathogen loaded/infected
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+ T cells represent an important effector arm of
the immune response in maintaining long-lived protective
immunity against intracellular pathogens such as viruses or some
intracellular bacteria [9]. Amongst these intracellular pathogens,
the bacterium Listeria monocytogenes (L.m) has been widely used as an
infection model to study memory CD8 responses. Upon recall
infection, L.m-specific memory CD8
+ T cells are able to control a
dose of bacteria otherwise lethal for non-immunized animals. This
rapid curving of bacterial growth occurs within a day or less,
questioning how these cells locate and induce pathogen killing in
such a small amount of time [10].
Memory T cells can be divided in two subsets based on the
expression of the LN homing receptors CD62L and CCR7.
Central memory T (TCM) cells are CD62L
+ CCR7
+ and
preferentially localize to the T cell zones of SLOs whereas effector
memory T (TEM) are CD62L
2 CCR7
2 and preferentially localize
to peripheral tissues [11]. The majority of the memory CD8
+ T
cells generated following L.m infection belongs to the TEM subset
and therefore poorly colonize the T cell zones of SLOs [12,13].
However, it has been suggested that memory CD8
+ T cells
reactivation is promoted by a cognate interaction with L.m-loaded
CD11c
+ cells that are known to migrate within a few hours to the
splenic T cell zone, a region where TEM poorly home [14,15,16].
In light of these observations, we addressed when and where
memory CD8
+ T cells are re-activated and provide their rapid
effector functions for early control of bacterial growth during a
secondary infection.
Results
Memory CD8
+ T cells control secondary L. monocytogenes
growth within the first hours of infection
To accurately determine when memory CD8
+ T cells start
controlling L.m growth during a secondary infection, we injected
mice intravenously (i.v) with PBS or 0.16LD50 Wt bacteria (10
4)
in order to induce a protective CD8 memory response. One
month later, CD8
+ T cells were eliminated or not with a depleting
anti-CD8b treatment and mice were challenged with
106LD50 Wt bacteria. Bacterial growth inside infected spleens
was then monitored 3, 6, 24 and 48 hours following infection. As
expected, immunized mice controlled the infection while CD8-
depleted and PBS-injected animals exhibited at least 1000 fold
more bacteria 24 hours after the challenge infection (Figure 1).
Most interestingly, the control of L.m growth by memory CD8
+ T
cells was already visible after 6 hours, suggesting that memory cells
not only had seen their cognate antigen at that time but had also
started to kill bacteria inside infected spleens.
L.m specific memory CD8
+ T cells are mostly found inside
the splenic red pulp
While naı ¨ve T cells traffic to the T cell zones of the SLOs, L.m-
specific memory T cells have been shown to patrol the splenic RP
and WP [17]. However, studies that visualized the behaviour of
memory CD8 T cells were done either using non-physiologic
numbers of naive T cell precursors and/or using approximate
landmarks such as T, B or MOMA-1 stainings [17,18].
Fibroblastic Reticular Cells (FRCs) residing in the T cell zones
of SLOs dictate the migration and define the territory of naı ¨ve T
lymphocytes in these organs [19]. As FRCs trespass in the B cell
follicles, they still support the migration of T cells in the follicles,
explaining the presence of sparse T cells adjacent to reticular fibers
in these areas. Most importantly, the collagen IV- and ERTR-7-
expressing reticular fibers they ensheat are reliable markers to
accurately localize them on tissue sections [20]. For these reasons,
we decided to use reticular fiber-specific markers to define the
exact location of memory CD8
+ T cells generated from a
physiological number of naive CD8
+ T cells precursors specific
for a L.m-expressed antigen. Since a normal mouse possesses
,200 T cells of a given specificity directed against a dominant
epitope [21,22,23,24] and CD8
+ T cells frequencies affects the
kinetics of their expansion and differentiation into effector and
memory cells [25], we adoptively transferred 200 GFP
+ OVA-
specific OT-I CD8
+ T cells (OT-I) in recipient mice that were
injected i.v the day after with 0.16LD50 Wt- or Wt-OVA
expressing bacteria. Spleens were sectioned 4, 6, 12 and 30 days
later and stained for B220, CD3, collagen IV expression
(Figure 2A). As expected, we were unable to detect any of the
200 OT-I cells in mice immunized with Wt bacteria (data not
shown). In Wt L.m-OVA infected animals, OT-I cells became
detectable 4 days after injection and were mainly localized in the
WP as previously observed [17]. At day 6, during their peak of
proliferation, OT-I cells had massively expanded and colonized
the RP where they predominantly remained during the contrac-
tion phase (day 12) and until day 30. In order to quantify these
observations, we calculated the densities of OT-I cells per mm
2 of
RP and WP at these different time points (Figure 2B). Data reveal
that the density of memory OT-I cells in the RP was two times
higher than in the WP, indicating that memory OT-I cells
predominantly colonize the RP of the spleen, correlating with the
observation that 2/3 of the OT-I isolated from the same spleen
belong to the TEM subset (CD62L
low CCR7
low, not shown).
Because memory OT-I cells have been reported to home to B
cell follicles, we focused on OT-I cells that were present in these
zones [17]. We observed that follicular OT-I cells were in contact
with adjacent collagen IV reticular fibers, suggesting that at least
some memory CD8
+ T cells present in follicles are indeed
patrolling ‘‘T cell zone embassies’’ created by residual FRCs
(Figure 3). Collectively, our results suggest that the majority of L.m-
specific memory CD8
+ T cells remains in the RP on steady state.
L.m-specific memory CD8
+ T cells are continuously
patrolling the blood system
The RP filters the blood content and can be assimilated to a
blood-filled sponge rather than a truly organised tissue like the WP
Figure 1. Memory CD8 T cells rapidly control secondary L.m
infection. Mice (3 per group) were infected i.v with PBS or immunized
with 0.16LD50 Wt L.m bacteria. 30 days later, animals were injected or
not with 100 mg of anti-CD8b depleting Ab i.p for three consecutive
days and then challenged with 7610
5 Wt bacteria. Bacteria titers in the
spleen were measured 3, 6, 24 and 48 hours later. Data are
representative of 2 independent experiments.
doi:10.1371/journal.pone.0011524.g001
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OT-I cells in the splenic RP may solely be the result of their
endless trafficking in the bloodstream. To test this hypothesis, we
adoptively transferred 200 GFP
+ OT-I cells in recipient mice that
were injected i.v. 1 day later with 0.16LD50 Wt or Wt-OVA-
expressing bacteria. One month later, 3610
6 polyclonal naı ¨ve
CD8
+ T cells were labelled with a Red tracker (CMTPX) and
injected i.v. in the mice in order to generate an internal control of
naı ¨ve T cell trafficking pattern. LNs, spleens, and blood cells were
stained for CD8 expression and analyzed by flow cytometry
(Figure 4A, upper panel). While the naive cells represented a stable
proportion of total CD8
+ T cells in the 3 compartments, memory
OT-I cells were poorly present in the LNs of primed animals but
more abundant in their blood and spleens, consistent with their
CD62L
low CCR7
low phenotype (not shown). Similar results were
obtained when following the endogenous memory CD8 response
generated against the naturally processed listeriolysin (LLO)-
derived epitope LLO91–99 presented by H-2K
d using LLO91–99/
Figure 2. Within the spleen, L.m specific memory CD8 T
+ cells predominantly reside in the Red Pulp. (A, B) 200 naı ¨ve GFP
+ OT-I cells were
transferred in C57BL/6 mice. One day after, recipient mice were injected i.v. with 0.16LD50 Wt L.m-OVA. Spleens were harvested 4, 6, 12 and 30 days
later, sectioned, stained for B220, CD3, collagen IV expression and analyzed by confocal microscopy. (B) The surfaces of WP and RP zones were
delineated based on collagen IV expression and summed up. The densities of memory GFP
+ OT-I cells per mm2 of each region were calculated and
displayed. Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0011524.g002
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d tetramers (Figure 4B, upper panel). Neither OT-I nor
LLO91–99/H-2K
d tet
+ cells were detected in mice injected 30 days
earlier with Wt bacteria or PBS respectively (not shown).
As memory OT-I cells were predominantly found in the blood
compartment of infected animals, we hypothesized that, unlike
naı ¨ve cells that continuously patrol SLOs, they may not be
retained in SLOs upon treatment with the S1P agonist FTY720, a
potent inhibitor of naı ¨ve lymphocyte egress from lymphoid organs
[27]. To address this question, L.m-immunized mice were injected
i.p with 100 mg of FTY720 and their spleens, LNs and blood were
Figure 3. L.m-specific memory CD8
+ T cells present in follicles are adjacent to reticular fibers. 200 naı ¨ve GFP
+ OT-I cells were transferred
in C57BL/6 mice that were injected i.v. the following day with 0.16LD50 Wt L.m-OVA. Spleens were harvested 30 days later, sectioned, stained for
B220, CD3, collagen IV expression and analyzed by confocal microscopy. Inserts show enlargements of B220
+ areas containing OT-I memory cells.
Data are representative of 2 different experiments.
doi:10.1371/journal.pone.0011524.g003
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lower panels). While -as expected- injection of FTY720 induced a
reduction of the naive population from the blood of treated
animals [27], OT-I and LLO91–99/H-2K
d tet
+ CD8
+ T cells were
highly enriched in the bloodstream. These results indicate that
memory CD8
+ T cells are poorly sensitive to the S1P agonist,
further confirming their peculiar trafficking pattern that may
prompt them to be more easily mobilized upon secondary
infection.
L.m specific memory CD8
+ T cells rapidly form clusters in
the RP during a recall infection
Because memory OT-I cells were predominantly found in the
RP and in the bloodstream of infected mice, we reasoned that the
early (6 hours) control of L.m growth should occur in the RP,
before infected cells have reached the WP. To investigate these
early events, 200 GFP
+ OT-I cells were adoptively transferred in
recipient mice that were injected 1 day later with 0.16LD50 Wt
L.m-OVA. After 30 days, animals were challenged with
Figure 4. L.m specific memory CD8
+ T cells preferentially traffic in the bloodstream. (A) 200 naı ¨ve GFP
+ OT-I cells were transferred in
C57BL/6 mice. One day later, recipient mice were injected i.v. with 0.16LD50 Wt L.m-OVA. Thirty days after this immunization, recipient mice were
injected i.v with 3610
6 naı ¨ve CMTPX-labelled polyclonal CD8
+ T cells. The following day, mice were injected i.p with PBS or 100 mg of FTY720. Animals
were killed 24 hours later and their LNs, spleen and blood harvested, stained for CD8 expression and analyzed by flow cytometry. Numbers indicate
the percentages of GFP
+ OT-I memory cells and CMTPX naive polyclonal CD8
+ T cells among total CD8
+ T cells. (B) Wt BALB/c mice were injected i.v
with 0.16LD50 Wt L.m and further treated as in (A) with the exception that polyclonal naive CD8
+ T cells were labelled with CFSE and that L.m specific
endogenous memory CD8
+ T cells were identified as LLO91–99/H-2K
d tetramers
+ CD8
+ cells. Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0011524.g004
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24 hours later, sectioned and stained for B220, CD3, and
collagen IV expression (Figure 5A). At 3 hours, memory OT-I
cells were present in the WP and the RP of re-infected animals in
the same proportions than untreated animals. Most interestingly,
at 6 hours, we observed the formation of OT-I clusters in the RP
of secondary infected animals (arrowheads). These clusters were
transient since they were largely crumbled after 12 hours and
completely dissolved at 24 hours, when OT-I cells had massively
relocated to the T cell zone (Figure 5A). Quantification of the
density of OT-I cells per mm
2 of RP and WP confirmed this
impression, indicating that a transient clustering of L.m-specific
memory CD8
+ T cells in the RP precedes their relocation to the
WP (Figure 5B).
L.m-specific memory ‘CD8 clusters’ concentrate immune
cells expressing antimicrobial effector functions
We next asked whether such early clustering of memory OT-I
cells may be related to the fast control of bacterial growth. We
previously demonstrated that reactivated L.m-specific CD8
+ Tc e l l s
rapidly secrete CCL3, a chemokine that promotes the antimicrobial
oxidative burst production in innate immune cells, an effector
function required for secondary protection against L.m [28]. Others
have also shown that memory CD8
+ T cells rapidly secrete IFN-c
Figure 5. L.m-specific memory CD8
+ T cells transiently form clusters in the Red Pulp of secondary infected animals. (A, B) 200 naı ¨ve
GFP
+ OT-I cells were transferred in C57BL/6 mice that were injected i.v. the following day with 0.16LD50 Wt L.m-OVA. One month later, mice were
injected i.v. with PBS or 106LD50 Wt L.m-OVA. Spleens were harvested 3, 6, 12 and 24 hours later, sectioned, stained for B220, CD3, collagen IV
expression and analyzed by confocal microscopy. Arrowheads indicate clusters of GFP
+ OT-I memory cells 6 hours post re-infection. (B) The surfaces
of WP and RP zones were delineated based on collagen IV expression and summed up. The densities of memory GFP
+ OT-I cells per mm2 of each
region were calculated and displayed. Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0011524.g005
Imaging CD8 Memory Response
PLoS ONE | www.plosone.org 6 July 2010 | Volume 5 | Issue 7 | e11524and that such secretion partially contributes to the protective recall
response [29,30]. Finally, several studies have demonstrated that
innate cells such as neutrophils and inflammatory monocytes
expressing the myeloid marker Ly-6C -also defined as TNF/NO-
producing DCs (Tip-DCs)- produce antimicrobial mediators known
to be critical for pathogens clearance [31,32]. Therefore, we
characterized the composition of the OT-I clusters induced 6 hours
afterthe challengeinfectionand looked forthepresenceofthe innate
immune cell types and effector functions described above. Spleens
sections from Wt L.m-OVA challenged mice (6 h) were stained for
theexpressionofB220,CD8,CD4(Figure6A);CD11c,L.mantigens
(Figure 6C) and CD8, IFN-c (Figure 6D). Attention was focused on
the clustersofmemoryOT-Icells.Datashowthattheseclusterswere
massive (.100 mm), composed of both CD4
+ and CD8
+ T cells (but
not B cells) and were usually found around L.m-infected CD11c
+
cells, similar to what was recently described during the secondary
challenge infection against Toxoplasma gondii in LNs [18]. Most
interestingly, we observed both on tissue sections and by flow
cytometry an intense IFN-c secretion by memory OT-I cells in these
clusters that we therefore named ‘‘effector clusters’’ (Figure 6D).
Although we were unable to detect CCL3 on sections, likely due to a
low expression of this chemokine, we did observe CCL3 secretion in
memory OT-I cells by flow cytometry. Interestingly, CCL3
expression was always observed in IFN-c secreting OT-I cells
(Figure 7). As IFN-c secretion by memory OT-I cells was only
observed in these effector clusters, we concluded that OT-I cells
secretingCCL-3 were alsolocalized intheseclusters.Todetermine if
neutrophils were also present there, we took advantage of the GFP-
expressing lys-M knock-in mouse in which neutrophils express high
amounts of GFP [33]. Massive and local accumulations of
neutrophils were indeed found in these clusters (Figure 6B), in
agreement with our previous study demonstrating that these cells
underwent activation at such early time following the secondary
infection [28]. Inflammatory monocytes produce radical oxygen
intermediates (ROI) critical for secondary protection against L.m
infections([28]andunpublisheddata).Astheseintermediatescannot
be detected by immunofluorescence, we used the ability of activated
inflammatory monocytes to express the inducible nitric oxide
synthase (iNOS) to locate these cells on tissue sections [34]. Spleen
sections of memory mice challenged for 3, 6, 12 and 24 hours with
wt L.m-OVA were stained for iNOS and collagen IV expression
(Figure 6E and Figure 8). At 6 hours, the peak of the effector cluster
formation, we failed to detect iNOS expression in agreement with
previous studies [34]. At 12 hours, however, iNOS expression was
detected in the OT-I remaining clusters localized in the RP,
suggesting that inflammatory monocytes activation and/or recruit-
ment also occurs in these clusters. At 24 hours, when the majority of
OT-I cells had relocalized to the WP, we were still able to visualize
patches of iNOS-expressing cells in the RP nearby OT-I cells. Thus
altogether, these results demonstrate that, very early after a
secondary infection, L.m-specific memory CD8
+ T cells aggregate
in clusters in the splenic RP where they release effector molecules
nearby L.m-infected innate immune cells. At the same time and later
on, neutrophils as well as inflammatory monocytes are also found in
these effector clusters producing antimicrobial mediators such as
ROI that are essential for the control of the secondary bacterial
burden [28].
Both L.m-specific and non-specific memory CD8
+ T cells
enter effector clusters and produce IFN-c, but only TCR-
triggered cells secrete CCL3
In vitro, memory CD8
+ T cells are able to rapidly secrete IFN-c
in response to inflammatory cytokines such as IL-12 and IL-18 in
absence of any TCR-triggering. Interestingly, Forman et al. have
demonstrated that this non-specific secretion contributes to the
control of L.m growth in the spleen of secondary infected mice
[29]. Therefore, we sought to determine if L.m-specific and non-
specific memory CD8
+ T cells were equally able to join the effector
clusters and express effector functions during secondary L.m
infection. To this aim, we adoptively transferred 200 GFP
+ OT-I
cells in recipient mice that were injected the day after with
0.16LD50 Wt L.m-OVA. One month later, mice were challenged
for 6 hours with 106LD50 Wt L.m or Wt L.m-OVA bacteria and
their spleens sectioned and stained for collagen IV expression
(Figure 9A). In order to compare if OT-I memory cells were able
to join effector clusters in absence of a specific TCR trigger, we
also co-stained these sections for CD8 expression and delineated 3
regions of interest: the entire splenic WP, the clusters of
endogenous CD8
+ T cells in the RP and the rest of the RP.
Densities of OT-I cells present in these 3 regions were calculated
(Figure 9B). Data show that memory OT-I cells were equally
capable to join effector clusters and secrete IFN-c to the same
proportion (,20% of all OT-I cells in both conditions) in mice
challenged with Wt L.m and Wt L.m-OVA, indicating that the
capacity of memory CD8
+ T cells to cluster and provide a rapid
response does not require antigen-specific re-activation of the cells
(Figure 9A, B and C).Interestingly, we detected CCL3 secretion by
memory OT-I cells only in the spleens isolated from animals
injected with Wt L.m-OVA, suggesting that memory CD8
+ T cells
need antigen-specific stimuli to secrete CCL3 in contrast to IFN-c
(Figure 7). Finally, we also investigated whether naı ¨ve OT-I cells
were able to join the effector clusters of secondary infected mice or
if this capacity was restricted to memory OT-I cells. For this, we
used the same experimental setup but adoptively transferred the
immunized mice with 3610
6 CMTPX-labelled naı ¨ve OT-I cells
before re-infection. Spleens were harvested 6 hours later, and the
densities of memory and naı ¨ve OT-I cells were calculated in the 3
regions of interest delineated above (Figure 9A and B). Data show
that naı ¨ve OT-I cells failed to integrate the effector clusters in both
groups of mice. However, as anticipated, naı ¨ve OT-I cells
aggregated in typical ‘‘activation clusters’’ only in the splenic
WP of mice challenged for 24 hours with Wt L.m-OVA (Figure 10
and [15]), indicating that naive CD8
+ T cell activation during a
secondary response takes place in the WP yet much after memory
CD8
+ T cells reactivation had occurred in the RP.
Discussion
Using L. monocytogenes as an infection model, we have
investigated the behaviour of memory CD8
+ T cells within the
first hours following a secondary bacterial infection. We observed
that memory CD8
+ T cells start to control L.m burden as early as
6 hours after the challenge infection. We found that this protection
correlated with several properties of these cells including (i) their
unique trafficking pattern, (ii) their rapid clustering in the RP upon
inflammation driven stimuli and (iii) their local, cluster-localized
release of several effector molecules triggered by antigen-
independent and dependent signals nearby other innate cell types
known to be important for L.m clearance.
A simple and obvious question emerges from these observations:
what is the purpose of these effector clusters?
First, these clusters may regulate memory CD8
+ T cells
reactivation. At steady state, the majority of memory CD8
+ T
cells traffic in the RP. As we and others observed that memory
OT-I cells migrate to the WP 24 hours after the challenge
infection in an Ag-dependent fashion (Figure 10, [17]), the only
place where these memory OT-I cells may have first encountered
their Ag is the RP (though later Ag recognition events in the WP
Imaging CD8 Memory Response
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zone 24 hrs after the challenge infection). Upon i.v. injection, L.m
enters the spleen in the marginal zone (MZ) where it is captured by
professional phagocytes [14,15,16]. Since memory CD8
+ T cells
are activated by CD11c
+ cells known to rapidly migrate from the
RP to the WP, memory CD8
+ T cells that do not patrol the WP
only have a small window of opportunity to encounter their Ag in
this location. This requirement correlates with our observation
Figure 6. Memory ‘CD8 clusters’ concentrate anti-listeria effector cells. (A,C,D,E) 200 naı ¨ve GFP
+ OT-I cells were transferred in C57BL/6 mice.
One day after, recipient mice as well as naive GFP
+ lys-M Tg mice (B) were injected i.v. with 0.16LD50 Wt L.m-OVA. One month later, all mice were
injected i.v. with 106LD50 Wt L.m-OVA. Spleens were harvested 6 (A,B,C,D) or 12 hrs later (E), sectioned, stained with anti-B220, -CD4, -CD8 (A); anti-
CD3, -collagen IV (B) anti-CD11c, -listeria (C); anti-IFN-c, and hoescht (D), anti-iNOS (E) specific Abs and analyzed by confocal microscopy. In (D), IFN-c
secretion by endogenous CD8
+ T cells and GFP
+ OT-I memory cells was also assessed by flow cytometry. Data are representative of 3 independent
experiments.
doi:10.1371/journal.pone.0011524.g006
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+ T cells are continuously patrolling the
blood circulation while avoiding the T cell zones of the SLOs. Of
note, the situation may be different for 1/3 of the memory OT-I
cells that patrol the WP and therefore may encounter the Ag for
the first time in this region.
The observation that memory CD8
+T cells preferentially patrol
the RP may either be dictated by some unknown attracting signal
or the consequence of their failure to enter the WP because of their
unresponsiveness to CCR7 ligands [35]. Interestingly, CD8
+ T
cells genetically modified to constitutively express CCR7 cannot
leave the WP and are impaired in their capacity to efficiently clear
a viral infection [36]. For these reasons, we believe that the
presence of memory CD8
+ T cells in the RP results from their
inability to enter in the WP and may be important for the rapid
release of effector functions upon L.m challenge. Along the same
line, the preferential trafficking of memory OT-I cells in the
bloodstream likely results from their inability to enter the LNs, a
phenomenon also observed in CD62L deficient mice [37]. Our
observation that memory CD8
+ T cells are poorly sensitive to the
S1P agonist FTY720 further suggests that in addition to their
homing properties, the egress of naive and memory CD8
+ T cells
from SLOs are differentially regulated. While we haven’t
investigated the member(s) of the S1P receptors family known to
be affected by FTY720, we can only speculate that S1P1, the
master player controlling naive lymphocyte egress from the LNs is
not expressed on memory CD8
+T cells that do not home to LNs.
Further experiments would be needed to test this hypothesis.
The biased patrolling of memory CD8
+ T cells may be crucial
for 2 reasons. First, if a L.m-specific memory CD8
+ T cell is
wandering for hours in the T cell zone of another SLO when L.m
arrives in the spleen, this cell will reach the spleen much after
pathogen-infected CD11c
+ cells have left the RP, therefore
preventing its reactivation. Second, blood circulating T cells enter
the spleen in the MZ, at the very same location than any i.v.
injected pathogens [38]. Since memory CD8
+ T cells traffic in the
blood compartment, they indeed have no other choice than
meeting the Ag-loaded CD11c
+ cells in the MZ even at the very
beginning of the infection. It is therefore interesting to point out
the similarity with the naı ¨ve T/DC activation clusters that form
nearby HEVs as soon as T cells leave the bloodstream and enter
the LN [5]. In both situations, these encounters are dictated by
SLO anatomy and aimed to the same goal: increasing the efficacy
of the searching process while decreasing its duration.
Second, besides their possible role in memory CD8
+ T cell
reactivation, these effector clusters may also be crucial for
controlling L.m growth. Since bacteria divide exponentially,
controlling their growth at the onset of the infection is essential.
Such control may either occur via a direct killing of infected cells
and/or by enhancing their microbicidal activities. Memory CD8
+
T cells can express rapid lytic functions involving perforin/
granzyme and Fas/Fas-L dependent pathways to lyse infected
cells. However, mice deficient for these molecules are protected
during secondary L.m infection, indicating that these mediators
may not be critical for protection. We have recently demonstrated
that CCL3 secreted by memory CD8
+ T cells is required for the
clearance of a secondary L.m infection [28]. CCL3 induces a rapid
TNF-a secretion by inflammatory monocytes that further
promotes the production of ROI in inflammatory monocytes and
neutrophils. Indeed, mice unable to produce ROI (phox47
2/2
mice) do not control a secondary L.m infection unless adoptively
transferred with Wt neutrophils or inflammatory monocytes,
demonstrating that ROI secretion by these cells is required for
secondary L.m killing. Likewise, IFN-c secretion by memory CD8
+
T cells also contributes to the control of a secondary L.m infection
since IFN-c
2/2 mice transferred with Wt but not IFN-c
2/2
memory CD8
+ T cells exhibit much less susceptibility to L.m
infection [29]. Because in vitro studies suggested that IFN-c
prevents bacterial escape from the phagosomes of infected
macrophages, it is likely that such indirect mechanism is
accounting for this IFN-c-dependent L.m killing in vivo [39].
Collectively, all these data support the hypothesis that indirect
killing orchestrated by L.m-specific memory cells is required for
secondary L.m protection. In line with this idea, we indeed
observed that professional phagocytes transiently aggregate in
Figure 7. Both L.m-specific and non-specific memory CD8
+ T cells produce IFN-c, but only TCR-triggered cells secrete CCL3. 200 naı ¨ve
GFP
+ OT-I cells were transferred in C57BL/6 mice that were injected i.v. the following day with 0.16LD50 Wt L.m-OVA. Thirty days after, recipient mice
were injected with 106LD50 Wt L.m or Wt L.m-OVA. Spleens were harvested 6 hours later, directly stained for IFN-c and CCL3 expression and
analyzed by flow cytometry. The numbers in the quadrants indicate the percentages of IFN-c
+ GFP
+ OT-I co-secreting or not CCL3.
doi:10.1371/journal.pone.0011524.g007
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memory CD8
+ T cells nearby professional phagocytes are likely
activating their microbicidal functions, eventually leading to
bacteria killing. Of note, the size and composition of these clusters
is reminiscent of the granulomas usually observed in slow growing
bacterial infections such as Mycobacterium tuberculosis or Mycobacte-
rium bovis/BCG infections [40,41]. Since the main function of
granulomas is to contain and prevent bacteria dissemination, it is
likely that the effector clusters generated in secondary L.m
infections have a similar purpose. Interestingly, similar to BCG
infections in which unspecific effector CD8
+ T cells enter the
granulomas, memory CD8
+ T cells entry into these clusters does
not depend on Ag recognition [42]. Collectively, these results
suggest that the capacity to form granuloma-like structure is a
feature of effector/memory-but not naı ¨ve CD8
+ T cells- that is
independent of their specificity.
Another unexpected finding of our work is that memory OT-I
cells were equally able to rapidly secrete IFN-c in response to Wt
L.m and Wt L.m-OVA challenges. In this regard, IFN-c secretion
by memory CD8
+ T cells mimics innate immune responses
triggered by pathogen-derived ‘‘danger signals’’. Interestingly, this
secretion can be induced by IL-12 and IL-18. Therefore, we can
speculate that L.m-induced inflammatory stimuli such as IL-12
and/or IL-18 (and others that remain to be defined) activate the
bystander secretion of IFN-c observed in memory CD8
+ T cells
[43,44]. On the contrary, CCL3 secretion by memory OT-I cells
only occurred after wt L.m-OVA re-infection, indicating that
CCL3, but not IFN-c secretion, requires an Ag-specific reactiva-
tion of the cells. Therefore, the delivery of CCL3 by memory
CD8
+ T is tightly regulated in a conventional ‘‘adaptive’’ manner.
These results demonstrate that memory CD8
+ T cells localized in
the same effector clusters are able to secrete various effector
molecules according to their reactivating stimuli. If both IFN-c
and CCL3 exhibit a potent pro-inflammatory activity on various
cell types, only CCL3 possesses chemotactic properties [45,46,47].
Therefore, we can speculate that a tight regulation of CCL3
secretion properly attracts responding cells while a broader IFN-c
secretion creates a local environment unfavorable to bacterial
growth as previously suggested by Forman et al. [29].
Finally, while effector clusters contained IFN-c secreting non-
specific memory CD8
+ T cells, they failed to recruit the L.m-
specific naive CD8
+ T cells. Several reasons may account for this
observation. It has been estimated that in a mouse, 50–200 naive
CD8
+ T cells are specific for a given MHC/peptide complex
[21,22,23,24]. In addition, naı ¨ve T cells endlessly patrol the T cell
zones of SLO in which they remain several hours. Therefore, it is
very unlikely that, if present in the bloodstream at the time of
infection, rare L.m specific CD8
+ T cells will home to the spleen
Figure 8. Inflammatory monocytes are activated/recruited to the effector clusters. 200 naı ¨ve GFP
+ OT-I cells were transferred in C57BL/6
mice that were infected i.v. the following day with 0.16LD50 Wt L.m-OVA. Thirty days after, recipient mice were injected with 106LD50 Wt L.m-OVA.
Spleens were harvested 3, 6, 12 and 24 hours later, sectioned, stained for iNOS, collagen IV expression and analyzed by confocal microscopy. Insert
shows an enlargement of an effector cluster. Data are representative of 2 different experiments.
doi:10.1371/journal.pone.0011524.g008
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high amounts of the L-selectin homing receptor [37]. Further-
more, upon a primary Wt L.m-OVA infection, the progeny of the
200 OT-I cells transferred into C57BL/6 mice represents ,1% of
total splenic CD8
+ T cells, outnumbering by several logs of
magnitude the number of endogenous L.m-specific naı ¨ve CD8
+ T
cells. Of note, we observed the same phenomenon while studying
the endogenous CD8
+ T cell response in BALB/c mice. Finally,
unlike effector and memory CD8
+ T cells, naı ¨ve T cells do not
possess any of the intermediate effector functions known to be
important for L.m clearance. Therefore, these results fit with the
inability of these cells to join the effector clusters.
Altogether, our results summarized in Figure 11 reveal how
memory CD8
+ T cells unique trafficking properties associated
to splenic anatomy result in the formation of transient
granulomas-like effector clusters in the RP of secondary
infected animals. Our observations provide a spatio-temporal
explanation to the subsequent cascade of effector functions that
ultimately results in an efficient control of bacterial burden very
early after re-infection.
Materials and Methods
Mice
BALB/c and C57BL/6 were purchased from Charles River
Laboratories (Les Oncins, France). OT-I TCR-transgenic mice
[48] were purchased from Taconic (Rockville, MD). C57BL/6
ubiquitin-GFP mice (UBI-GFP/BL6, strain 4353) were pur-
Figure 9. L.m-specific and non-specific memory CD8
+ T cells aggregate in effector clusters and secrete IFN-c upon L.m reinfection.
200 naı ¨ve GFP
+ OT-I cells were transferred in C57BL/6 mice that were injected i.v. the following day with 0.16LD50 Wt L.m-OVA.. Thirty days after,
recipient mice were injected with 3610
6 naı ¨ve CMTPX labelled OT-I cells. The following day, mice were injected i.v. with 106LD50 Wt L.m or Wt L.m-
OVA. Spleens were harvested 6 hours later, sectioned, stained for collagen IV (A) or IFN-c (C) expression and analyzed by confocal microscopy. In C,
IFN-c secretion by endogenous CD8
+ T cells and memory GFP
+ OT-I cells was also assessed by flow cytometry. (B) Spleen sections were stained for
collagen IV and CD8 expression. The surfaces of 3 regions of interest were drawn: the WP, the RP area containing endogenous CD8 clusters and the
rest of the RP. The densities of memory GFP
+ OT-I and naı ¨ve CMTPX OT-I cells per mm2 of each region of interest were calculated and displayed. Data
are representative of 2 different experiments.
doi:10.1371/journal.pone.0011524.g009
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while C57BL/6 LysM-EGFP mice were a gift from T. Graf
(Albert Einstein College of Medicine, NY). All mice were
maintained in the animal facilities of the Centre d’Immuno-
logie de Marseille-Luminy and used between 6 and 12 weeks of
age unless specified. Unless specified, groups of mice were
composed of 2 animals. All research involving animals has
been specifically approved by the ethical committee of the
Universite ´d el aM e ´diterrane ´e and the regional committee of
the co ˆte d’azur.
Bacteria, infections and measure of bacterial titers
Wild type and recombinant L.m expressing the gene for OVA
(Wt L.m-OVA) were grown as described previously ([28]). Wt
L.m-OVA was a kind gift from Dr. Hao Shen (U. Penn, PA,
USA). For L.m infections, bacteria were grown to a logarithmic
phase in broth heart infusion (BHI) medium (Sigma Aldrich)
diluted in PBS and injected i.v in the retro-orbital vein. In all
experiments, mice were primary immunized with a 0.16LD50 of
bacteria (3610
3 Wt L.m or 10
4 Wt L.m-OVA). L.m expressing
OVA exhibits a lower LD50 than the non-expressing one.
Figure 10. L.m-specific naı ¨ve CD8 T
+ cells are reactivated in the WP. 200 naı ¨ve GFP
+ OT-I cells were transferred in C57BL/6 mice that were
injected i.v. the following day with 0.16LD50 Wt L.m-OVA. One month later, recipient mice were injected i.v. with 3610
6 naı ¨ve CMTPX labelled OT-I
cells. One day after, mice were injected i.v. with 106LD50 Wt L.m or Wt L.m-OVA. Spleens were harvested 24 hrs later, sectioned, stained for collagen
IV expression and analyzed by confocal microscopy. Inserts show the clusterization of naı ¨ve OT-I cells in the WP of Wt L.m-OVA challenged animals.
Data are representative of 2 different experiments.
doi:10.1371/journal.pone.0011524.g010
Figure 11. Summary. At the steady state, while splenic L.m-specific naive CD8
+ T cells reside in the WP, L.m specific memory cells preferentially
traffic in the RP as a result of their increased patrolling of the blood system. Within six hours post L.m re-infection, clusters of cells rapidly form around
L.m-infected cells in the splenic RP of challenged animals. These clusters contain several immune effector cells that express antimicrobial activities
such as IFN-c and CCL3 secreting memory CD8
+ T cells, neutrophils and Tip-DCs. Importantly, the capacity to join these clusters and secrete IFN-c is
independent of TCR recognition but requires the CD8
+ T cells to belong to the memory lineage. Because these clusters that involve many
antimicrobial effector cells and molecules occur at the exact same time when L.m burden starts to be controlled by memory CD8
+ T cells, we believe
that they may be the first site where L.m infection is controlled during a recall splenic infection.
doi:10.1371/journal.pone.0011524.g011
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of virulence which is a more general phenomenon observed in
infectious agents [49]. Secondary infections were performed 1
month later with 3610
5 Wt L.m or Wt L.m-OVA. To measure
bacterial titers in the spleen, organs were harvested and
dissociated on metal screens in 10 ml of 0.1% triton X-100
(Sigma Aldrich). Serial dilutions were performed in the same
buffer, and 100 ml was plated onto BHI media plates. CFU
numbers were counted 24 hours later.
Adoptive transfers
T cells were purified from the LNs of OT1 TCR-transgenic
mice or Wt animals using a pan T cell isolation kit (Miltenyi
Biotec, Auburn, California) and stained with either CFSE (2 mM)
or CMTPX (5 mM) (Invitrogen, Carlsbad, California) at 37uC for
15 min. The indicated numbers of cells were transferred into host
mice by intravenous injection.
FTY720 and anti-CD8b treatment
When indicated, mice received 100 mg of FTY720 (Cayman
Chemical Company, MI, USA) intraperitoneally and were killed
24 hours later. In order to deplete CD8 T cells, mice were injected
100 mg of anti-CD8b depleting Ab (clone H35-17-2) intraperito-
neally for three consecutive days.
Antibodies
ERTR-7 antibody specific for an unknown FRC-secreted
molecule was purchased from Acris Antibodies (Hiddenhausen,
Germany). RA3-6B2 antibody specific for B220, 17A2 specific for
the CD3 complex, XMG1.2 specific for IFN-c, 11B11 specific for
IL-4, RM4-5 specific for CD4, 5326.7 specific for CD8 were from
BD Biosciences Pharmingen (San Diego, CA). Rabbit polyclonal
anti-collagen IV antibody was purchased from Abcam (Cam-
bridge, MA). Anti listeria Rabbit serum was purchased from Difco
(Lawrence, KS). Rabbit polyclonal anti-NOS-2 antibody was
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Rabbit polyclonal anti-GFP antibody was purchased from
Invitrogen (Carlsbad, CA). Goat polyclonal anti-mouse CCL3
antibody was purchased from R&D Systems (MN, USA). These
antibodies were visualized by direct coupling to allophycocyanin,
pacific-blue, Alexa fluor 2488, 2568, 2647, or through the use of
Alexa fluor 2488, 2568, or 2647 coupled secondary antibodies
(Invitrogen, Carlsbad, CA). PE-conjugated LLO91–99/H-2Kd
tetramers were provided by the NIH (Bethesda, MD).
Flow cytometry
Cells were stained with the specified antibodies in 100 ml of PBS
containing 0.5% BSA (FACS buffer). For intracellular staining,
spleens were digested for 20 min in collagenase I (400 U/ml,
Invitrogen, Carlsbad, CA) and directly incubated for 20 min on
ice with the indicated cell surface marker mAbs, fixed with the
FACS buffer for 10 min on ice (BD Cytofix/Cytoperm), and
permeabilized for 2 min (BD Perm/Wash). Cells were incubated
for 20 min on ice in BD Perm/Wash containing anti–IFN-c (clone
XMG1.2) or anti-IL-4 (clone 11B11) Ab as control rat IgG1. cells
were washed and analyzed on a FACSCalibur cytofluorometer
(Becton Dickinson).
Immunostaining
Spleens were cut in 3 pieces and fixed 1 hr with 8 ml of 2%
paraformaldehyde in PBS, washed in phosphate buffer, and
dehydrated in 30% sucrose in phosphate buffer for 12 hrs. Spleens
were snap frozen in Tissue-TekH (Sakura Finetek). 20 mm frozen
sections were cut and then stained with the indicated antibodies as
previously described. Immunofluorescence confocal microscopy
was performed using a Leica TCS SP5 confocal microscope.
Separate images were collected for each fluorochrome and
overlaid to obtain a multicolor image. Final image processing
was performed using ImageJ software (National Institutes of
Health) and Adobe Photoshop.
Quantification of the OT-I densities in the WP and RP
areas
Immunofluorescence images were segmented into WP and RP
areas according to the collagen IV staining. The numbers of pixels
of each area as well as the numbers of OT-I were measured using
ImageJ software (National Institutes of Health). Finally, densities of
OT-I cells per mm2 of WP and RP were calculated. For each
condition, a minimum of 20 different fields were counted per
spleen, representing an area of interest .3m m
2.
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